English
简体中文
Total: £ 56.28
Published Date: 2025-07-24 | Pages: 102 | Tables: 107 | Pharma & Healthcare
The global market for Animal Autogenous Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Animal autogenous vaccines are used to treat various animal infections, including but not limited to dermatitis, sinusitis, otitis externa, pharyngitis, laryngitis and mastitis that may be induced by Gram-positive or Gram-negative bacteria, dermatophytes and yeasts.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 260%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal Autogenous Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Autogenous Vaccines.
The Animal Autogenous Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal Autogenous Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Autogenous Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boehringer Ingelheim International
ZOETIS
Gallant Custom Laboratories
Ceva Biovac
Dyntec sro
UVAXX Pte Ltd
Deltamune Animal Health
Genova Labs
Hygieia Biological Laboratories
Vaxxinova
Elanco Animal Health
Addison Biological Laboratory
Phibro Animal Health Corporation
Lohmann Tierzucht
RIPAC-LABOR GmbH
Aquatic Biologicals
Merck
BS-IMMUN GmbH
Ridgeway Biologicals
Segment by Type
Poultry
Pigs
Cattles
Fishes
Other
Segment by Application
Large Farms
Family Farms
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal Autogenous Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal Autogenous Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Animal Autogenous Vaccines Market Overview
1.1 Product Definition
1.2 Animal Autogenous Vaccines by Type
1.2.1 Global Animal Autogenous Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Poultry
1.2.3 Pigs
1.2.4 Cattles
1.2.5 Fishes
1.2.6 Other
1.3 Animal Autogenous Vaccines by Application
1.3.1 Global Animal Autogenous Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Large Farms
1.3.3 Family Farms
1.4 Global Animal Autogenous Vaccines Market Size Estimates and Forecasts
1.4.1 Global Animal Autogenous Vaccines Revenue 2020-2031
1.4.2 Global Animal Autogenous Vaccines Sales 2020-2031
1.4.3 Global Animal Autogenous Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Animal Autogenous Vaccines Market Competition by Manufacturers
2.1 Global Animal Autogenous Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Animal Autogenous Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Animal Autogenous Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Animal Autogenous Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Animal Autogenous Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal Autogenous Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Animal Autogenous Vaccines, Date of Enter into This Industry
2.8 Global Animal Autogenous Vaccines Market Competitive Situation and Trends
2.8.1 Global Animal Autogenous Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Animal Autogenous Vaccines Players Market Share by Revenue
2.8.3 Global Animal Autogenous Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Animal Autogenous Vaccines Market Scenario by Region
3.1 Global Animal Autogenous Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Animal Autogenous Vaccines Sales by Region: 2020-2031
3.2.1 Global Animal Autogenous Vaccines Sales by Region: 2020-2025
3.2.2 Global Animal Autogenous Vaccines Sales by Region: 2026-2031
3.3 Global Animal Autogenous Vaccines Revenue by Region: 2020-2031
3.3.1 Global Animal Autogenous Vaccines Revenue by Region: 2020-2025
3.3.2 Global Animal Autogenous Vaccines Revenue by Region: 2026-2031
3.4 North America Animal Autogenous Vaccines Market Facts & Figures by Country
3.4.1 North America Animal Autogenous Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Animal Autogenous Vaccines Sales by Country (2020-2031)
3.4.3 North America Animal Autogenous Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Animal Autogenous Vaccines Market Facts & Figures by Country
3.5.1 Europe Animal Autogenous Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Animal Autogenous Vaccines Sales by Country (2020-2031)
3.5.3 Europe Animal Autogenous Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal Autogenous Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Animal Autogenous Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Animal Autogenous Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Animal Autogenous Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Animal Autogenous Vaccines Market Facts & Figures by Country
3.7.1 Latin America Animal Autogenous Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Animal Autogenous Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Animal Autogenous Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal Autogenous Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal Autogenous Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Animal Autogenous Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Animal Autogenous Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Animal Autogenous Vaccines Sales by Type (2020-2031)
4.1.1 Global Animal Autogenous Vaccines Sales by Type (2020-2025)
4.1.2 Global Animal Autogenous Vaccines Sales by Type (2026-2031)
4.1.3 Global Animal Autogenous Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Animal Autogenous Vaccines Revenue by Type (2020-2031)
4.2.1 Global Animal Autogenous Vaccines Revenue by Type (2020-2025)
4.2.2 Global Animal Autogenous Vaccines Revenue by Type (2026-2031)
4.2.3 Global Animal Autogenous Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Animal Autogenous Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Animal Autogenous Vaccines Sales by Application (2020-2031)
5.1.1 Global Animal Autogenous Vaccines Sales by Application (2020-2025)
5.1.2 Global Animal Autogenous Vaccines Sales by Application (2026-2031)
5.1.3 Global Animal Autogenous Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Animal Autogenous Vaccines Revenue by Application (2020-2031)
5.2.1 Global Animal Autogenous Vaccines Revenue by Application (2020-2025)
5.2.2 Global Animal Autogenous Vaccines Revenue by Application (2026-2031)
5.2.3 Global Animal Autogenous Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Animal Autogenous Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim International
6.1.1 Boehringer Ingelheim International Company Information
6.1.2 Boehringer Ingelheim International Description and Business Overview
6.1.3 Boehringer Ingelheim International Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim International Animal Autogenous Vaccines Product Portfolio
6.1.5 Boehringer Ingelheim International Recent Developments/Updates
6.2 ZOETIS
6.2.1 ZOETIS Company Information
6.2.2 ZOETIS Description and Business Overview
6.2.3 ZOETIS Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ZOETIS Animal Autogenous Vaccines Product Portfolio
6.2.5 ZOETIS Recent Developments/Updates
6.3 Gallant Custom Laboratories
6.3.1 Gallant Custom Laboratories Company Information
6.3.2 Gallant Custom Laboratories Description and Business Overview
6.3.3 Gallant Custom Laboratories Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gallant Custom Laboratories Animal Autogenous Vaccines Product Portfolio
6.3.5 Gallant Custom Laboratories Recent Developments/Updates
6.4 Ceva Biovac
6.4.1 Ceva Biovac Company Information
6.4.2 Ceva Biovac Description and Business Overview
6.4.3 Ceva Biovac Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Biovac Animal Autogenous Vaccines Product Portfolio
6.4.5 Ceva Biovac Recent Developments/Updates
6.5 Dyntec sro
6.5.1 Dyntec sro Company Information
6.5.2 Dyntec sro Description and Business Overview
6.5.3 Dyntec sro Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dyntec sro Animal Autogenous Vaccines Product Portfolio
6.5.5 Dyntec sro Recent Developments/Updates
6.6 UVAXX Pte Ltd
6.6.1 UVAXX Pte Ltd Company Information
6.6.2 UVAXX Pte Ltd Description and Business Overview
6.6.3 UVAXX Pte Ltd Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 UVAXX Pte Ltd Animal Autogenous Vaccines Product Portfolio
6.6.5 UVAXX Pte Ltd Recent Developments/Updates
6.7 Deltamune Animal Health
6.7.1 Deltamune Animal Health Company Information
6.7.2 Deltamune Animal Health Description and Business Overview
6.7.3 Deltamune Animal Health Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Deltamune Animal Health Animal Autogenous Vaccines Product Portfolio
6.7.5 Deltamune Animal Health Recent Developments/Updates
6.8 Genova Labs
6.8.1 Genova Labs Company Information
6.8.2 Genova Labs Description and Business Overview
6.8.3 Genova Labs Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Genova Labs Animal Autogenous Vaccines Product Portfolio
6.8.5 Genova Labs Recent Developments/Updates
6.9 Hygieia Biological Laboratories
6.9.1 Hygieia Biological Laboratories Company Information
6.9.2 Hygieia Biological Laboratories Description and Business Overview
6.9.3 Hygieia Biological Laboratories Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hygieia Biological Laboratories Animal Autogenous Vaccines Product Portfolio
6.9.5 Hygieia Biological Laboratories Recent Developments/Updates
6.10 Vaxxinova
6.10.1 Vaxxinova Company Information
6.10.2 Vaxxinova Description and Business Overview
6.10.3 Vaxxinova Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Vaxxinova Animal Autogenous Vaccines Product Portfolio
6.10.5 Vaxxinova Recent Developments/Updates
6.11 Elanco Animal Health
6.11.1 Elanco Animal Health Company Information
6.11.2 Elanco Animal Health Description and Business Overview
6.11.3 Elanco Animal Health Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elanco Animal Health Animal Autogenous Vaccines Product Portfolio
6.11.5 Elanco Animal Health Recent Developments/Updates
6.12 Addison Biological Laboratory
6.12.1 Addison Biological Laboratory Company Information
6.12.2 Addison Biological Laboratory Description and Business Overview
6.12.3 Addison Biological Laboratory Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Addison Biological Laboratory Animal Autogenous Vaccines Product Portfolio
6.12.5 Addison Biological Laboratory Recent Developments/Updates
6.13 Phibro Animal Health Corporation
6.13.1 Phibro Animal Health Corporation Company Information
6.13.2 Phibro Animal Health Corporation Description and Business Overview
6.13.3 Phibro Animal Health Corporation Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Phibro Animal Health Corporation Animal Autogenous Vaccines Product Portfolio
6.13.5 Phibro Animal Health Corporation Recent Developments/Updates
6.14 Lohmann Tierzucht
6.14.1 Lohmann Tierzucht Company Information
6.14.2 Lohmann Tierzucht Description and Business Overview
6.14.3 Lohmann Tierzucht Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Lohmann Tierzucht Animal Autogenous Vaccines Product Portfolio
6.14.5 Lohmann Tierzucht Recent Developments/Updates
6.15 RIPAC-LABOR GmbH
6.15.1 RIPAC-LABOR GmbH Company Information
6.15.2 RIPAC-LABOR GmbH Description and Business Overview
6.15.3 RIPAC-LABOR GmbH Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 RIPAC-LABOR GmbH Animal Autogenous Vaccines Product Portfolio
6.15.5 RIPAC-LABOR GmbH Recent Developments/Updates
6.16 Aquatic Biologicals
6.16.1 Aquatic Biologicals Company Information
6.16.2 Aquatic Biologicals Description and Business Overview
6.16.3 Aquatic Biologicals Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Aquatic Biologicals Animal Autogenous Vaccines Product Portfolio
6.16.5 Aquatic Biologicals Recent Developments/Updates
6.17 Merck
6.17.1 Merck Company Information
6.17.2 Merck Description and Business Overview
6.17.3 Merck Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Merck Animal Autogenous Vaccines Product Portfolio
6.17.5 Merck Recent Developments/Updates
6.18 BS-IMMUN GmbH
6.18.1 BS-IMMUN GmbH Company Information
6.18.2 BS-IMMUN GmbH Description and Business Overview
6.18.3 BS-IMMUN GmbH Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.18.4 BS-IMMUN GmbH Animal Autogenous Vaccines Product Portfolio
6.18.5 BS-IMMUN GmbH Recent Developments/Updates
6.19 Ridgeway Biologicals
6.19.1 Ridgeway Biologicals Company Information
6.19.2 Ridgeway Biologicals Description and Business Overview
6.19.3 Ridgeway Biologicals Animal Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Ridgeway Biologicals Animal Autogenous Vaccines Product Portfolio
6.19.5 Ridgeway Biologicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal Autogenous Vaccines Industry Chain Analysis
7.2 Animal Autogenous Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal Autogenous Vaccines Production Mode & Process Analysis
7.4 Animal Autogenous Vaccines Sales and Marketing
7.4.1 Animal Autogenous Vaccines Sales Channels
7.4.2 Animal Autogenous Vaccines Distributors
7.5 Animal Autogenous Vaccines Customer Analysis
8 Animal Autogenous Vaccines Market Dynamics
8.1 Animal Autogenous Vaccines Industry Trends
8.2 Animal Autogenous Vaccines Market Drivers
8.3 Animal Autogenous Vaccines Market Challenges
8.4 Animal Autogenous Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Animal Autogenous Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Animal Autogenous Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Animal Autogenous Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Animal Autogenous Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Animal Autogenous Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Animal Autogenous Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Animal Autogenous Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Animal Autogenous Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Animal Autogenous Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Animal Autogenous Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Animal Autogenous Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Animal Autogenous Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Animal Autogenous Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Autogenous Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Animal Autogenous Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Animal Autogenous Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Animal Autogenous Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Animal Autogenous Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Animal Autogenous Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Animal Autogenous Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Animal Autogenous Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Animal Autogenous Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Animal Autogenous Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Animal Autogenous Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Animal Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Animal Autogenous Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Animal Autogenous Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Animal Autogenous Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Animal Autogenous Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Animal Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Animal Autogenous Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Animal Autogenous Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Animal Autogenous Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Animal Autogenous Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Animal Autogenous Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Animal Autogenous Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Animal Autogenous Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Animal Autogenous Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Animal Autogenous Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Animal Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Animal Autogenous Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Animal Autogenous Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Animal Autogenous Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Animal Autogenous Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Animal Autogenous Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Animal Autogenous Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Animal Autogenous Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Animal Autogenous Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Animal Autogenous Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Animal Autogenous Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Animal Autogenous Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Animal Autogenous Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Animal Autogenous Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Animal Autogenous Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Animal Autogenous Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Animal Autogenous Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Animal Autogenous Vaccines Price (US$/Unit) by Type (2020-2025)
Table 59. Global Animal Autogenous Vaccines Price (US$/Unit) by Type (2026-2031)
Table 60. Global Animal Autogenous Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Animal Autogenous Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Animal Autogenous Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Animal Autogenous Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Animal Autogenous Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Animal Autogenous Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Animal Autogenous Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Animal Autogenous Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Animal Autogenous Vaccines Price (US$/Unit) by Application (2020-2025)
Table 69. Global Animal Autogenous Vaccines Price (US$/Unit) by Application (2026-2031)
Table 70. Boehringer Ingelheim International Company Information
Table 71. Boehringer Ingelheim International Description and Business Overview
Table 72. Boehringer Ingelheim International Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Boehringer Ingelheim International Animal Autogenous Vaccines Product
Table 74. Boehringer Ingelheim International Recent Developments/Updates
Table 75. ZOETIS Company Information
Table 76. ZOETIS Description and Business Overview
Table 77. ZOETIS Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. ZOETIS Animal Autogenous Vaccines Product
Table 79. ZOETIS Recent Developments/Updates
Table 80. Gallant Custom Laboratories Company Information
Table 81. Gallant Custom Laboratories Description and Business Overview
Table 82. Gallant Custom Laboratories Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Gallant Custom Laboratories Animal Autogenous Vaccines Product
Table 84. Gallant Custom Laboratories Recent Developments/Updates
Table 85. Ceva Biovac Company Information
Table 86. Ceva Biovac Description and Business Overview
Table 87. Ceva Biovac Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Ceva Biovac Animal Autogenous Vaccines Product
Table 89. Ceva Biovac Recent Developments/Updates
Table 90. Dyntec sro Company Information
Table 91. Dyntec sro Description and Business Overview
Table 92. Dyntec sro Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Dyntec sro Animal Autogenous Vaccines Product
Table 94. Dyntec sro Recent Developments/Updates
Table 95. UVAXX Pte Ltd Company Information
Table 96. UVAXX Pte Ltd Description and Business Overview
Table 97. UVAXX Pte Ltd Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. UVAXX Pte Ltd Animal Autogenous Vaccines Product
Table 99. UVAXX Pte Ltd Recent Developments/Updates
Table 100. Deltamune Animal Health Company Information
Table 101. Deltamune Animal Health Description and Business Overview
Table 102. Deltamune Animal Health Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Deltamune Animal Health Animal Autogenous Vaccines Product
Table 104. Deltamune Animal Health Recent Developments/Updates
Table 105. Genova Labs Company Information
Table 106. Genova Labs Description and Business Overview
Table 107. Genova Labs Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Genova Labs Animal Autogenous Vaccines Product
Table 109. Genova Labs Recent Developments/Updates
Table 110. Hygieia Biological Laboratories Company Information
Table 111. Hygieia Biological Laboratories Description and Business Overview
Table 112. Hygieia Biological Laboratories Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Hygieia Biological Laboratories Animal Autogenous Vaccines Product
Table 114. Hygieia Biological Laboratories Recent Developments/Updates
Table 115. Vaxxinova Company Information
Table 116. Vaxxinova Description and Business Overview
Table 117. Vaxxinova Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Vaxxinova Animal Autogenous Vaccines Product
Table 119. Vaxxinova Recent Developments/Updates
Table 120. Elanco Animal Health Company Information
Table 121. Elanco Animal Health Description and Business Overview
Table 122. Elanco Animal Health Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Elanco Animal Health Animal Autogenous Vaccines Product
Table 124. Elanco Animal Health Recent Developments/Updates
Table 125. Addison Biological Laboratory Company Information
Table 126. Addison Biological Laboratory Description and Business Overview
Table 127. Addison Biological Laboratory Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Addison Biological Laboratory Animal Autogenous Vaccines Product
Table 129. Addison Biological Laboratory Recent Developments/Updates
Table 130. Phibro Animal Health Corporation Company Information
Table 131. Phibro Animal Health Corporation Description and Business Overview
Table 132. Phibro Animal Health Corporation Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Phibro Animal Health Corporation Animal Autogenous Vaccines Product
Table 134. Phibro Animal Health Corporation Recent Developments/Updates
Table 135. Lohmann Tierzucht Company Information
Table 136. Lohmann Tierzucht Description and Business Overview
Table 137. Lohmann Tierzucht Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Lohmann Tierzucht Animal Autogenous Vaccines Product
Table 139. Lohmann Tierzucht Recent Developments/Updates
Table 140. RIPAC-LABOR GmbH Company Information
Table 141. RIPAC-LABOR GmbH Description and Business Overview
Table 142. RIPAC-LABOR GmbH Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. RIPAC-LABOR GmbH Animal Autogenous Vaccines Product
Table 144. RIPAC-LABOR GmbH Recent Developments/Updates
Table 145. Aquatic Biologicals Company Information
Table 146. Aquatic Biologicals Description and Business Overview
Table 147. Aquatic Biologicals Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Aquatic Biologicals Animal Autogenous Vaccines Product
Table 149. Aquatic Biologicals Recent Developments/Updates
Table 150. Merck Company Information
Table 151. Merck Description and Business Overview
Table 152. Merck Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Merck Animal Autogenous Vaccines Product
Table 154. Merck Recent Developments/Updates
Table 155. BS-IMMUN GmbH Company Information
Table 156. BS-IMMUN GmbH Description and Business Overview
Table 157. BS-IMMUN GmbH Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. BS-IMMUN GmbH Animal Autogenous Vaccines Product
Table 159. BS-IMMUN GmbH Recent Developments/Updates
Table 160. Ridgeway Biologicals Company Information
Table 161. Ridgeway Biologicals Description and Business Overview
Table 162. Ridgeway Biologicals Animal Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Ridgeway Biologicals Animal Autogenous Vaccines Product
Table 164. Ridgeway Biologicals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Animal Autogenous Vaccines Distributors List
Table 168. Animal Autogenous Vaccines Customers List
Table 169. Animal Autogenous Vaccines Market Trends
Table 170. Animal Autogenous Vaccines Market Drivers
Table 171. Animal Autogenous Vaccines Market Challenges
Table 172. Animal Autogenous Vaccines Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Animal Autogenous Vaccines
Figure 2. Global Animal Autogenous Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Animal Autogenous Vaccines Market Share by Type: 2024 & 2031
Figure 4. Poultry Product Picture
Figure 5. Pigs Product Picture
Figure 6. Cattles Product Picture
Figure 7. Fishes Product Picture
Figure 8. Other Product Picture
Figure 9. Global Animal Autogenous Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Animal Autogenous Vaccines Market Share by Application: 2024 & 2031
Figure 11. Large Farms
Figure 12. Family Farms
Figure 13. Global Animal Autogenous Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Animal Autogenous Vaccines Market Size (2020-2031) & (US$ Million)
Figure 15. Global Animal Autogenous Vaccines Sales (2020-2031) & (K Units)
Figure 16. Global Animal Autogenous Vaccines Average Price (US$/Unit) & (2020-2031)
Figure 17. Animal Autogenous Vaccines Report Years Considered
Figure 18. Animal Autogenous Vaccines Sales Share by Manufacturers in 2024
Figure 19. Global Animal Autogenous Vaccines Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Animal Autogenous Vaccines Players: Market Share by Revenue in Animal Autogenous Vaccines in 2024
Figure 21. Animal Autogenous Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Animal Autogenous Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Animal Autogenous Vaccines Sales Market Share by Country (2020-2031)
Figure 24. North America Animal Autogenous Vaccines Revenue Market Share by Country (2020-2031)
Figure 25. United States Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Animal Autogenous Vaccines Sales Market Share by Country (2020-2031)
Figure 28. Europe Animal Autogenous Vaccines Revenue Market Share by Country (2020-2031)
Figure 29. Germany Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Animal Autogenous Vaccines Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Animal Autogenous Vaccines Revenue Market Share by Region (2020-2031)
Figure 36. China Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Animal Autogenous Vaccines Sales Market Share by Country (2020-2031)
Figure 46. Latin America Animal Autogenous Vaccines Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Animal Autogenous Vaccines Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Animal Autogenous Vaccines Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Animal Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Animal Autogenous Vaccines by Type (2020-2031)
Figure 56. Global Revenue Market Share of Animal Autogenous Vaccines by Type (2020-2031)
Figure 57. Global Animal Autogenous Vaccines Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Animal Autogenous Vaccines by Application (2020-2031)
Figure 59. Global Revenue Market Share of Animal Autogenous Vaccines by Application (2020-2031)
Figure 60. Global Animal Autogenous Vaccines Price (US$/Unit) by Application (2020-2031)
Figure 61. Animal Autogenous Vaccines Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
